Role of human HGFIN/nmbin breast cancer
Open Access
- 10 September 2007
- journal article
- Published by Springer Science and Business Media LLC in Breast Cancer Research
- Vol. 9 (5), R58
- https://doi.org/10.1186/bcr1764
Abstract
HGFIN, previously identified as nmb, and its homolog osteoactivin are single transmembrane proteins that are expressed in differentiated immune cells. These proteins exhibit properties that could potentiate tumorigenesis or decrease invasiveness. These seemingly opposing roles of HGFIN suggest that this protein might be central to malignancies and might also behave as a tumor suppressor. Consistent with the reported roles for HGFIN is the fact that this gene is regulated by p53 through multiple binding sites in the 5' flanking region, and is expressed in osteoblasts.This publication has 27 references indexed in Scilit:
- p53: a two-faced cancer geneNature, 2007
- DC-HIL is a negative regulator of T lymphocyte activationBlood, 2007
- Osteoactivin acts as downstream mediator of BMP‐2 effects on osteoblast functionJournal of Cellular Physiology, 2006
- The anti-proliferative effect of neurokinin-A on hematopoietic progenitor cells is partly mediated by p53 activating the 5′ flanking region of neurokinin-2 receptorCellular Signalling, 2006
- Glycoprotein Nonmetastatic Melanoma Protein B, a Potential Molecular Therapeutic Target in Patients with Glioblastoma MultiformeClinical Cancer Research, 2006
- Osteoactivin upregulates expression of MMP-3 and MMP-9 in fibroblasts infiltrated into denervated skeletal muscle in miceAmerican Journal of Physiology-Cell Physiology, 2005
- Expression of osteoactivin in rat and human liver and isolated rat liver cellsJournal of Hepatology, 2005
- An in vitro method to select malignant cells from surgical biopsies of breast cancer patientsBiological Procedures Online, 2005
- Bone-related Genes Expressed in Advanced Malignancies Induce Invasion and Metastasis in a Genetically Defined Human Cancer ModelOnline Journal of Public Health Informatics, 2003
- nmb, a novel gene, is expressed in low‐metastatic human melanoma cell lines and xenograftsInternational Journal of Cancer, 1995